NASDAQ:FBIO
Fortress Biotech Stock News
$1.79
-0.0200 (-1.10%)
At Close: Apr 24, 2024
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024
12:24pm, Thursday, 11'th Apr 2024
Biotech stocks can offer some of the most explosive, exciting opportunities on the market. That is, if you find the right one.
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
08:30am, Friday, 15'th Mar 2024
Company to host conference call to discuss financial results and provide a corporate update on March 21, 2024 at 4:30 p.m. ET Company to host conference call to discuss financial results and provide a
Best Penny Stocks To Buy This Week? 4 To Watch Now
10:17am, Monday, 20'th Nov 2023
Whether you're looking at the “ Magnificent Seven stocks ,” or just the next round of penny stocks to watch, news & company events can quickly sway sentiment. This week is a short holiday week wit
11 Top Penny Stocks To Buy Now According To Insiders
01:32pm, Friday, 17'th Nov 2023
Ever wonder what signals to look for in the stock market today? Let's talk about insider buying – a goldmine of clues that could lead you to the next prospect to add to your list of penny stocks to
Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023
08:30am, Tuesday, 31'st Oct 2023
Company to host conference call to discuss financial results and provide a corporate update on November 7, 2023 at 4:30 p.m. ET Company to host conference call to discuss financial results and provide
Fortress Biotech to Present at ROTH MKM 2023 Healthcare Opportunities Conference
08:30am, Thursday, 05'th Oct 2023
Fortress Biotech will present at the ROTH MKM 2023 Healthcare Opportunities Conference in New York City on Thursday, October 12, 2023, at 11:00 a.m. ET.
Fortress Biotech to Present at H.C. Wainwright 25th Annual Global Investment Conference
08:30am, Thursday, 07'th Sep 2023
MIAMI, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializi
Fortress Biotech to Present at the BTIG Virtual Biotechnology Conference 2023
08:30am, Thursday, 03'rd Aug 2023
MIAMI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializin
Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023
08:30am, Wednesday, 19'th Jul 2023
Company to host conference call to discuss financial results and provide a corporate update the week of August 7, 2023 Company to host conference call to discuss financial results and provide a corpor
Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 22, 2023
04:01pm, Friday, 19'th May 2023
Company to host conference call to discuss financial results and provide a corporate update on May 22, 2023 at 4:30 p.m. ET Company to host conference call to discuss financial results and provide a c
Fortress Biotech (FBIO) Reports Q1 Loss, Lags Revenue Estimates
06:59pm, Monday, 15'th May 2023
Fortress Biotech (FBIO) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.18 per share a year ago.
Journey Medical Corporation to Announce Year End 2022 Financial Results on March 29, 2023
09:00am, Wednesday, 22'nd Mar 2023
Company to host conference call to discuss financial results and provide a corporate update on March 29, 2023 at 4:30 p.m. ET Company to host conference call to discuss financial results and provide a
Fortress Biotech to Participate in Two March 2023 Investor Conferences
08:00am, Tuesday, 07'th Mar 2023
MIAMI, March 07, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializi
Fortress Biotech (FBIO) Reports Q3 Loss, Misses Revenue Estimates
10:25pm, Monday, 14'th Nov 2022 Zacks Investment Research
Fortress Biotech (FBIO) delivered earnings and revenue surprises of 7.41% and 13.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Bellus Health (BLU) Reports Q3 Loss, Misses Revenue Estimates
10:15pm, Monday, 14'th Nov 2022 Zacks Investment Research
Bellus (BLU) delivered earnings and revenue surprises of -11.11% and 60%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?